ArticleFrontiers in immunology2024

Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer.

Xiaofang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.